Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Healthcare
Biotechnology
1.20 $
+2.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Telomir Pharmaceuticals, Inc. Common Stock (TELO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -1.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -2.0 | -1.1 | -1.9 | -1.5 | -1.0 | -0.6 | -0.9 | -0.7 | -0.9 | -1.2 | -1.8 | -4.6 | |
| – | – | – | 4.3 | – | – | – | – | – | – | – | – | – | |
| – | – | – | 0.0 | 0.0 | 4.8 | 2.1 | 1.4 | 4.7 | -0.7 | 0.8 | 0.0 | 4.8 | |
| 1.4 | -1.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.1 | 0.0 | -0.3 | 0.1 | 0.9 | -0.8 | -0.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.4 | |
| 0.0 | 2.0 | 1.1 | 5.2 | 0.1 | 0.0 | 1.0 | 0.0 | 1.0 | 7.5 | 1.2 | 0.0 | 9.8 | |
| 0.0 | 0.0 | 0.0 | 3.3 | -1.4 | -1.0 | 0.4 | -0.9 | 0.4 | 6.6 | 0.0 | -1.7 | 5.2 | |
| 0.0 | -2.0 | -1.1 | -1.9 | -1.5 | -1.0 | -0.6 | -0.9 | -0.7 | -0.9 | -1.2 | -1.8 | -4.6 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.